laboratory-automation
(7)
H.E.L Group Wants Your Chemistry to Survive the Factory
A reaction that behaves on a laboratory bench can become a different proposition at production scale. H.E.L Group builds the reactors, calorimeters and control software that help scientists investigate the gap.
Susan Golightly Trusts the Question More Than the Dashboard
Long before every company promised to be data-driven, Susan Golightly was asking the less fashionable question: what will people actually do with all that information? Her career has been an argument for curiosity, context, and the patient work of turning evidence into action.
The Lab Software That Turned Three Hours of Data Review Into 45 Minutes
Indigo BioAutomation built a quiet business around an expensive laboratory habit: highly trained scientists checking good data one result at a time. Its bet is that software should clear the routine cases and make humans spend their attention on the exceptions.
STARLIMS Built the Operating System for Labs - Now It Has to Make 40 Years of Complexity Feel Simple
The laboratory software veteran survived an IPO, a $123 million sale, a 12-year corporate hibernation and a private-equity rebirth. Its next experiment is harder: turning a sprawling enterprise stack into one usable thread from scientific idea to released product.
The Lab Test That Found Its Market in Cannabis - Then Went Hunting for Salmonella
PathogenDx spent years turning a three-dimensional DNA microarray into a commercial test. Cannabis labs supplied the opening; poultry processors may supply the scale.
Galatek
Galatek is a Singapore-based automation and AI company building intelligent infrastructure for two sectors where precision and data integrity matter most: life sciences and advanced semiconductor manufacturing. It pairs robotics and machine vision with software - its Abio platform unifying ELN, LIMS, SDMS and lab automation, and its InteVega AI vision platform - to run smart labs and inspect chips. Led by CEO David Tian, Galatek raised roughly US$30 million in a Series A round announced in December 2025 to expand across Europe, North America and Southeast Asia.
Pleno Inc.
Pleno Inc. is a San Diego multi-omic instrument company rebuilding the economics of biological target detection. Its RAPTOR platform, powered by proprietary Hypercoding technology borrowed from telecommunications signal processing, can detect up to 10,000 targets in a single sample at PCR-like speed and cost. Founded by serial entrepreneur Pieter van Rooyen, the company is moving from R&D into commercial launch with backing from Deerfield Management and Foresite Capital.